Skip to main content
HRL $24.54 +0.41%
HRL logo

HRL · Hormel Foods Corp /De/

Track HRL — free
$24.54 +0.10 (+0.41%) At close · Aug 14
Market Cap
$13.50B
Shares
550.31M
All earnings calls

Earnings call · FY2026 Q1

Hormel Foods Corp /De/ Q1 FY2026 Earnings Call

Hormel Foods Corp /De/ Q1 FY2026 Earnings Call

Concluded Feb 26, 2026 Audio replay
Feb 26, 2026 55:25 36 turns
Period
FY2026 Q1
Runtime
55:25
Sources
4 artifacts

Executive readout · one minute

What matters this quarter

Hormel reported Q1 fiscal 2026 net sales of $3.03 billion with 2% organic net sales growth and adjusted diluted EPS of $0.34, marking its fifth consecutive quarter of organic net sales growth, led by Foodservice and International while Retail declined. The company reaffirmed its full-year organic net sales and adjusted diluted EPS guidance and announced a definitive agreement to sell its whole-bird turkey business to Life-Science Innovations.

Protein-Centric Portfolio 37 Foodservice and International Strength 30 Pricing Actions 30 Organic Net Sales Growth 29 Whole-Bird Turkey Divestiture 22 Full-Year Guidance 19

Management tone

Positive

Net tone +25 · low hedging

Grounding quotes
  • “We are pleased to report solid results for the first quarter of fiscal 2026.”
  • “the solid start to fiscal 2026 gives us conviction as we look ahead”
  • “we know there is more work ahead, and we are committed to executing with urgency and precision”
  • “In light of the logistics cost trend, we think our confirmation of both our top and bottom line annual guidance range should be seen as a prudent yet confident sign.”

Forward guidance

10 guided metrics

Management's latest ranges and targets are included below.

Research coverage

4 live sources

Switch sources without leaving this page or losing your listening position.

Revenue $3.03B +1.3% YoY
Diluted EPS $0.33 +6.5% YoY
Gross margin 15.5% -0.4 pp YoY
Net income $181.80M +6.6% YoY

Research materials

Open the source you need; every reader stays inside this workspace.

Key takeaways

What improved, and what deserves a closer read.

Constructive signals

  • Achieved fifth consecutive quarter of organic net sales growth at 2% and adjusted diluted EPS of $0.34, described as $0.02 ahead of the bottom line target after Q1.
  • Foodservice segment delivered its 10th consecutive quarter of organic net sales growth with high single-digit organic net sales growth and segment profit growth, driven by premium prepared proteins and branded pepperoni.
  • International segment posted high single-digit organic net sales growth with impressive segment profit growth.
  • Reaffirmed full-year fiscal 2026 guidance: organic net sales growth of 1% to 4% and adjusted diluted EPS of $1.43 to $1.51, reflecting 4% to 10% growth.
  • Cash flow from operations of $349 million in the quarter.
  • Announced definitive agreement to sell the whole-bird turkey business to Life-Science Innovations, expected to close by end of fiscal Q2, to reduce exposure to volatile commodity-driven businesses and focus on value-added Jennie-O products.

Risks & pressure points

  • Retail segment organic volume and organic net sales declined in Q1, impacted by the strategic exit from select non-core private label snack nuts items.
  • Retail profitability was pressured by expected increases in raw material costs and unexpected increases in logistics expenses.
  • GAAP operating income guidance was updated to $1.02 billion to $1.08 billion and GAAP diluted EPS guidance was updated to $1.37 to $1.46, reflecting impacts from the Justin's branded business sale.
  • Q2 fiscal 2026 adjusted diluted EPS is expected to be flat to slightly up versus the prior-year quarter.
  • Retail net sales expected to remain in low single digits or flat for the year, with anticipated modest volume declines.

Key moments

Jump directly to management's words in the synchronized transcript.

“For Q2, we expect to deliver another quarter of top line growth and adjusted diluted EPS that is in the range of flat to slightly up compared to last year. For the full year, we have also reaffirmed our organic net sales and adjusted diluted earnings per share guidance.” Jeffrey Ettinger, CEO
“This transaction supports our goal of reducing our exposure to volatile commodity-driven businesses and sharpening our focus on our value-added protein portfolio.” Jeffrey Ettinger, CEO

Forward guidance

From the 8-K filed Feb 26, 2026.

Metric Guided
Net Sales
fiscal 2026
$12.2B – $12.5B
Organic Net Sales Growth Rate
fiscal 2026
1% – 4%
Adjusted Operating Income
fiscal 2026
$1.06B – $1.12B
Operating Income
fiscal 2026
$1.02B – $1.08B
Adjusted Diluted Earnings per Share
fiscal 2026
$1.43 – $1.51
Diluted Earnings per Share
fiscal 2026
$1.37 – $1.46
Net Sales (GAAP) table
Fiscal 2026
$12.2B – $12.5B
Organic Net Sales (Non-GAAP) table
Fiscal 2026
$12.2B – $12.5B
Operating income (GAAP)
Fiscal 2026
$1.02B – $1.08B
Adjusted operating income (Non-GAAP)
Fiscal 2026
$1.06B – $1.12B

Quarter detail

How the reported period landed and where the business moved.

Revenue · segments

Retail Segment$1.85B -2.2% YoY
Foodservice Segment$998.23M +7.3% YoY
International Segment$181.28M +7.6% YoY

Capital returned

Dividend / share
$0.29
Full-screen source Call document